About 100,000 Americans have sickle cell disease (SCD), the most common inherited blood disorder in the US. Roughly 10% of ...

Huntsville Hospital is expanding care options for patients with blood disorders, launching a new outpatient red blood cell ...

Scientists have long been puzzled by how maturing red blood cells manage to produce all the hemoglobin they need to carry ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...

Scientists have long been puzzled by how maturing red blood cells manage to produce all the hemoglobin they need to carry ...

Some health issues are easy to spot and feel on the outside, but they become complicated when they affect the inside, including your blood. A new survey by LloydsPharmacy Online Doctor reveals that 75 ...

What Is Cablivi, and Why Does It Matter? Cablivi (caplacizumab) is an injectable medicine used to treat a rare and serious blood condition called acquired thrombotic thrombocytopenic purpura (aTTP).

Add Yahoo as a preferred source to see more of our stories on Google. A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019.

On Thursday, Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) announced that the ACTIVATE-Kids Phase 3 study of mitapivat in children aged 1 to <18 years with PK deficiency who are not regularly transfused ...